From: The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Management | Non-COVID group n = 2412 | COVID group n = 180 | p |
---|---|---|---|
Primary radiological diagnosis | 0.19 | ||
Ultrasound | 1604 (66.9%) | 110 (61.8%) | |
CT scan | 795 (33.1%) | 68 (38.2%) | |
Delay in intervention (h) | 45.9 (110.1) | 63.44 (201.4) | 0.89 |
Surgery | p < 0.0001 | ||
Laparoscopic total cholecystectomy | 1401 (76.6%) | 75 (58.1%) | |
Laparoscopic total cholecystectomy and intraoperative cholangiography | 135 (7.4%) | 10 (7.8%) | |
Laparoscopic partial cholecystectomy | 21 (1.1%) | 1 (0.8%) | |
Open total cholecystectomy | 123 (6.7%) | 29 (22.5%) | |
Open total cholecystectomy and intraoperative cholangiography | 17 (0.9%) | 2 (1.6%) | |
Open partial cholecystectomy after conversion | 18 (1%) | 1 (0.8%) | |
Open partial cholecystectomy | 17 (0.9%) | 2 (1.6%) | |
Open total cholecystectomy after conversion | 98 (5.4%) | 9 (0.7%) | |
Adequate source control | 2206 (94.6%) | 158 (93.5%) | 0.48 |
Adequate empirical antibiotics | 2317 (97.9%) | 169 (95.5%) | 0.48 |
Reoperation | 55 (2.6%) | 10 (14.6%) | 0.011 |
Strategy for reoperation | 0.11 | ||
Laparoscopy | 16 (23.9) | 2 (15.4) | |
On demand laparotomy | 16 (23.9) | 3 (23.1) | |
Planned laparotomy | 7 (10.4) | 5 (38.5) | |
Radiological intervention | 28 (41.8) | 3 (23.1) | |
Ventilation | 67 (2.8%) | 30 (16.8%) | p < 0.0001 |
Ventilation time (days) | 5 (6.6) | 4.55 (4.1) | 0.67 |
Parenteral nutrition | 145 (6.1%) | 39 (22.2%) | p < 0.0001 |
Parenteral nutrition time (days) | 4.01 (4.78) | 6.95 (6.5) | p = 0.001 |